Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Abroad (travel likely)RecruitingPHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Acute Myeloid Leukemia
Locations
- US-Cincinnati OH-CINCY, Cincinnati, Ohio, United States
- DE-Ulm-UNIKLINKULM, Ulm, Germany
- NL-Breda-AMPHIA, Breda, Netherlands
- NL-Eindhoven-MAXIMAMC, Eindhoven, Netherlands
- NL-Leeuwarden-FRISIUSMC, Leeuwarden, Netherlands
- NL-Nieuwegein-ANTONIUS, Nieuwegein, Netherlands
- NL-Rotterdam-ERASMUCMC, Rotterdam, Netherlands
- NL-Den Haag-HAGA, The Hague, Netherlands